Specialty healthcare company Endo International Plc offered to purchase Auxilium Pharmaceuticals Inc for about $2.2 billion in cash and stock to expand its men's healthcare products business.Auxilium, which said in June it would buy Canadian eye drug maker QLT Inc in an all-stock deal to move its headquarters to lower-tax British Columbia, was not immediately available for comment.Endo said it sent a proposal to Auxilium on Friday but had not received an official response.Endo's offer of $28.10 per share represents a premium of 30.6 percent to Auxilium's Tuesday closing price of $21.52 on the Nasdaq.
Auxilium Pharmaceuticals, Inc. is a specialty biopharmaceutical company focuses on developing and marketing products to predominantly specialist audiences. Shares of AUXL fell by 1.56% or $-0.34/share to $21.52. In the past year, the shares have traded as low as $16.36 and as high as $32.89. On average, 1233350 shares of AUXL exchange hands on a given day and today's volume is recorded at 1168189.
QLT Inc., is a biotechnology company. The Company is engaged in the development and commercialization of ocular products. Shares of QLT fell by 1.58% or $-0.11/share to $6.85. In the past year, the shares have traded as low as $4.33 and as high as $7.90. On average, 4987 shares of QLT.TO exchange hands on a given day and today's volume is recorded at 835.
QLT Inc., is a biotechnology company. The Company is engaged in the development and commercialization of ocular products. Shares of QLTI fell by 1.74% or $-0.11/share to $6.20. In the past year, the shares have traded as low as $4.16 and as high as $7.10. On average, 180200 shares of QLTI exchange hands on a given day and today's volume is recorded at 26234.
Source
